Rapid RV/LV vs iCAC Device

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by RapidAI
VS
by Bunkerhill Health

AI Verdict

Tool A, Rapid RV/LV, is designed for the rapid assessment of pulmonary embolism severity by measuring right and left ventricle ratios from CTPA scans. Conversely, Tool B, iCAC Device, focuses on detecting and quantifying coronary artery calcium from routine, non-contrast chest CT scans to aid in early cardiovascular disease detection. While both are FDA-cleared AI tools for cardiac imaging, they address distinct clinical conditions and utilize different types of CT scans.

Choose Rapid RV/LV if…

Choose Rapid RV/LV if your primary need is the rapid, AI-powered assessment of pulmonary embolism severity from CTPA scans. This tool is ideal for emergency departments and critical care settings where quick and objective measurement of right and left ventricle ratios is crucial for patient triage and guiding immediate treatment decisions for suspected or confirmed PE.

View Rapid RV/LV →

Choose iCAC Device if…

Choose iCAC Device if your goal is opportunistic screening for cardiovascular disease by detecting and quantifying coronary artery calcium from routine, non-contrast chest CT scans. This tool is best suited for identifying patients at risk for coronary artery disease from existing imaging data, allowing for proactive risk stratification and earlier intervention in a broader patient population.

View iCAC Device →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Rapid RV/LV iCAC Device
Pricing Contact vendor for pricing information. Contact for pricing
Deployment Unknown Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform).
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Rapid RV/LV

Rapid RV/LV emphasizes rapid results, triage, and notification capabilities through its integrated platform, including mobile and web apps, for acute care scenarios. This focus on immediate, coordinated communication for critical decision-making suggests a highly dynamic and responsive user experience. While iCAC also offers seamless integration, its primary focus is on opportunistic detection rather than acute response.

Clinical Value

Tie

Both tools offer significant and distinct clinical value. Rapid RV/LV provides rapid assessment of pulmonary embolism severity, aiding in faster triage and treatment for an acute, life-threatening condition. The iCAC Device enables opportunistic detection and quantification of coronary artery calcium from routine scans, facilitating early intervention for chronic cardiovascular disease and potentially reducing long-term costs. Both are FDA-cleared and address critical needs in cardiovascular care.

Pricing & Value

Tie

Both Rapid RV/LV and iCAC Device require contacting the vendor for pricing information, making a direct comparison of their cost-effectiveness impossible. However, both offer substantial value through improved clinical outcomes, enhanced efficiency, and potential cost savings in their respective domains of acute care and opportunistic screening.

Enterprise Readiness

Rapid RV/LV

RapidAI explicitly states its HIPAA compliance and BAA availability in the structured facts, which are crucial for enterprise adoption. Furthermore, its extensive deployment in thousands of hospitals across over 100 countries and flexible on-premises or hybrid deployment options demonstrate proven scalability and robust infrastructure for enterprise environments. While Bunkerhill Health integrates with PACS/DICOM and EHRs, its compliance details are listed as 'contact vendor for details'.

Innovation

iCAC Device

The iCAC Device's innovation lies in its ability to opportunistically detect and quantify coronary artery calcium from routine, non-contrast, non-gated chest CT scans, leveraging existing data for early disease detection without requiring additional dedicated imaging. This proactive approach to identifying at-risk individuals from incidental findings represents a significant advancement in preventive care and population health management. Rapid RV/LV's automation of RV/LV ratio measurement is also innovative but addresses a more focused acute care workflow.

Support & Docs

Rapid RV/LV

RapidAI offers comprehensive support, including 24/7/365 customer service via email and phone, extensive online resources like webinars, case studies, and guides, and a formal 'Advanced Training Certification Program' with CE credits. Bunkerhill Health's publicly available information on support and documentation is less detailed, primarily consisting of news, case studies, and a workflow library.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Rapid RV/LV iCAC Device
Tool Name Rapid RV/LV iCAC Device
Company RapidAI (formerly iSchemaView) Bunkerhill Health
Primary Clinical Focus Rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans. Detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans, aiding in early cardiovascular disease detection.
Input Scan Type CTPA scans Routine, non-contrast, non-gated chest CT scans
Key Output/Measurement Automated measurement of right and left ventricle diameters, calculation of RV/LV ratio, annotated images showing ventricular measurements. Estimates presence and quantity of coronary artery calcium (CAC), visual representation of estimated CAC segmentation, exact and four-category quantitative estimates of CAC burden in Agatston units.
Specialties Supported Cardiology, Pulmonology, Radiology Cardiology, Radiology

Videos

Demos, reviews, and walkthroughs featuring Rapid RV/LV and iCAC Device.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Rapid RV/LV by RapidAI is designed for the rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans. Bunkerhill Health's iCAC Device detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans to aid in early cardiovascular disease detection.
Rapid RV/LV specifically analyzes CTPA scans to assess ventricular ratios. In contrast, the iCAC Device analyzes routine, non-contrast, non-gated chest CT scans to identify and quantify coronary artery calcium.
Rapid RV/LV provides automated measurements of right and left ventricle diameters and calculates the RV/LV ratio, along with annotated images. The iCAC Device delivers exact and four-category quantitative estimates of coronary artery calcium burden in Agatston units, including a visual representation of estimated CAC segmentation.
Rapid RV/LV supports Cardiology, Pulmonology, and Radiology specialties. The iCAC Device primarily supports Cardiology and Radiology specialties.
Rapid RV/LV connects to the hospital LAN/firewall and integrates with the broader Rapid PE solution. The iCAC Device integrates with PACS or DICOM routers and can integrate with EHRs via the Carebricks platform.
Rapid RV/LV provides rapid results within minutes of a scan, reducing inter-rater variability and offering triage and notification capabilities for pulmonary embolism severity. The iCAC Device offers adjunctive information to radiologists by opportunistically identifying and quantifying coronary artery calcium from existing CT scans, supporting early cardiovascular disease detection.
AI Tool Finder
AI-powered search. Results may not be comprehensive.